Excellos vs ImmunoACT
Excellos
A unique full-service CDMO, setting new standards in Cell & Gene Therapy
38 employees · est. 2021 · San Diego, United States
ImmunoACT is the older company (2021 vs 2018); ImmunoACT is the larger of the two.
Side-by-Side Comparison
| Metric | Excellos | ImmunoACT |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2018 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Navi Mumbai, India |
| Employees | ||
| Employees | 38 | 99 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology |
| Funding Stage | ||
| Funding Stage | Corporate Round | Corporate Round |
| Total Funding | ||
| Total Funding | $20.00M | $1.40B |
| Funding Rounds | ||
| Funding Rounds | 3 | 3 |
| Taxonomy | ||
| Taxonomy | Cell And Gene TherapyCDMOCGMP ManufacturingTIL TherapiesCAR-T TherapyImmunotherapy +8 | Cell TherapyGene TherapyIIT-BombayStartupTranslational ResearchViral Vector Process Development +5 |
| Website | ||
| Website | excellos.com | ImmunoACT.com |
About Excellos
Excellos is a biotechnology startup based in the United States, founded in 2021. It operates as a unique full-service CDMO, focusing on cell and gene therapy innovation. Leveraging the expertise and resources of the San Diego Blood Bank with over 70 years of experience, Excellos aims to set a new in...
About ImmunoACT
ImmunoACT is a pioneering biotechnology startup, proudly based in India, that specializes in the development of indigenous Cell & Gene Therapy. Founded in 2018 as a spin-out from IIT-Bombay, the company has quickly established itself as a leader in the field, with a strong focus on addressing unmet...
Also comparing in this category
Comparing more than these two?
Get Excellos, ImmunoACT and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Excellos compare?
A PDF of Excellos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Excellos with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Excellos on 11 Sep 2024, and ImmunoACT on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.